First Green Light In US For ED Drug OTC Switch Actual Use Trial Goes To Opella For Cialis
ACNU Self-Selection Platform Becomes Full Focus Of US Firm Petros
Opella says FDA “lifted a clinical hold on its planned actual use trial to support the switch of Cialis” while Petros Pharmaceuticals shifts from working on its own ED-switch proposals to developing a proprietary technology-assisted platform designed for use in consumers’ self-selection of drugs made available in ACNU proposals.
